What are the signs that show I need cataract surgery? “There are several key signs that someone may need cataract surgery,” ...

Abbott announced that the Food and Drug Administration (FDA) has approved the Tecnis Symfony Intraocular Lenses for the treatment of cataracts. Abbott announced that the Food and Drug Administration ...

Between 1998 and 2004 at one Swiss hospital, 133 eyes (78 patients) underwent placement of a V4 model implantable Collamer® lens (ICL; Staar Surgical, Monrovia, California), a phakic posterior chamber ...

Surgically implanting lenses in the eyes of infants born with cataracts might increase the rate of surgical complications, said a Baylor College of Medicine eye specialist who took part in a study ...

The new approvals are the latest in Johnson & Johnson’s IOLs; the Company claims the new TECNIS Eyhance IOL can slightly extend the depth of focus and deliver better image contrast. The Food and Drug ...

Cataracts are cloudy areas in the lens of the eye. They are common as you age. According to the National Eye Institute, more than half of adults in the United States over the age of 80 have cataracts ...

Santa Ana-based Abbott Medical Optics, a unit of Abbott Laboratories in Chicago, scored a regulatory approval this month. Abbott Medical said the Food and Drug Administration approved its Tecnis ...

A total of 77 eyes (77 patients) who underwent CE with posterior chamber intraocular lens (PCIOL) implantation following GFS by a single surgeon were reviewed. Main outcome measures were preoperative ...

Abbott has earned FDA approval for its Tecnis Symfony Intraocular Lenses for the treatment of cataracts. The approval includes the Tecnis Symfony Toric IOL, a version of the lenses that are made for ...

To investigate the long-term visual results after cataract extraction in patients with uveitis, and to demonstrate the long-term viability of intraocular lenses. In all, 61 patients (72 eyes), with ...

SANTA ANA, Calif., Feb. 2, 2021 /PRNewswire/ -- Johnson & Johnson Vision**, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies***, today announced that the U.S.